Clinical trial for Insomnia
Official title Enhancing Hypnotic Medication Discontinuation in Primary Care
ClinicalTrials.gov ID: NCT06435520
What this study is testing
- What it's testing
- The study compares a combined digital CBT for insomnia and medication tapering program with medication tapering alone to see which reduces sleep‑pill use and improves sleep symptoms.
- Who it's for
- Adults who regularly take hypnotic sleep medications and have insomnia, recruited from primary care clinics.
- What's involved
- Participants will either receive a digital CBT program and taper their medication or just taper their medication. They will have clinic visits, complete online therapy modules, and keep sleep diaries.
- Time commitment
- The trial lasts about 6 months, with several clinic visits and regular check‑ins to monitor medication use and sleep quality.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- will be used to enroll individuals who are: (1) 18 years of age or older
You likely can't join if
- for this study include: (1) a lifetime diagnosis of any psychotic disorder, a lifetime diagnosis of a bipolar disorder, or suicide attempts within...
- Zolpidem (Ambien, Ambien CR)
- Lorazepam (Ativan)
- Clonazepam (Klonopin)
- Eszopiclone (Lunesta)
- Temazepam (Restoril)
See the full eligibility criteria
- will be used to enroll individuals who are: (1) 18 years of age or older; (2) able to read and effectively communicate in English (without the use of a translator), as study resources are not available in other...
- for this study include: (1) a lifetime diagnosis of any psychotic disorder, a lifetime diagnosis of a bipolar disorder, or suicide attempts within the last 3 years
- Zolpidem (Ambien, Ambien CR)
- Lorazepam (Ativan)
- Clonazepam (Klonopin)
- Eszopiclone (Lunesta)
- Temazepam (Restoril)
- Zaleplon (Sonata)
- Alprazolam (Xanax)
- Diazepam (Valium)
- Trazodone (Desyrel)
- Doxepin (Silenor)
- Quetiapine (Seroquel), ≤100mg only
- Mirtazapine (Remeron)
- Hydroxyzine (Vistaril)
- Doxepin (Silenor)
- Prazepam (Centrax)
- Flurazepam (Dalmane)
- Quazepam (Doral)
- Triazolam (Halcion)
- Cholordiazepoxide (Librium)
- Halazepam (Paxipam)
- Estazolam (Prosom)
- Oxazepam (Serax)
- Clorazepate (Tranxene)
The study team makes the final eligibility decision.
Where it is enrolling
- Denver, Colorado, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Denver, Colorado, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.